ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Markets

Pfizer vaccine hopes give Asia markets a shot in the arm

Developers report initial 'success' but analysts warn of long rollout

TOKYO/NEW YORK -- Investors in Asian markets snapped up pandemic-hit stocks on Tuesday on hopes of a breakthrough against COVID-19 after drugmaker Pfizer indicated its candidate vaccine had proved more than 90% effective in its most widespread trial.

Japan's equity benchmark Nikkei Stock Average at one point surged over 400 points, or 1.7%, on Tuesday morning, reaching the 25,000 threshold for the first time in 29 years. The broader Topix also jumped over 1% and reached its highest point in nine months.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more